Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
SIPCO, LLC v. Emerson Electric Co., Appeal No. 2018-1635 (Fed. Cir. Sept. 25, 2019)
In this appeal of the Patent Trial and Appeal Board’s (PTAB) final written decision regarding covered business method (CBM) review of SIPCO’s U.S. Patent No. 8,908,842 (“the ’842 patent”), the Federal Circuit addresses issues relating to claim construction and eligibility for CBM review.
The ’842 patent concerns the use of a “low-power” remote transceiver configured to wirelessly transmit a signal with instruction data for delivery to a network of devices. Two dependent claims of the ’842 patent allow for the remote device to be associated with a vending machine or an ATM.
ALSO THIS WEEK
Campbell Soup Company v. Gamon Plus, Inc., Appeal Nos. 2018-2029, -2030 (Fed. Cir. Sept. 26, 2019)
In an appeal from an inter parties review, the Court addressed whether the PTAB erred in finding two design patents not invalid for obviousness. On appeal, the court addressed the standard to find a piece of prior art sufficient to qualify as a primary reference for such an analysis. The Court vacated the PTAB’s findings and partially remanded the claims, because “the ever-so-slight differences in [the] design [of one of the patents], in light of the overall similarities,” created “basically the same visual impression as the claimed designs,” and thus allowed that reference to qualify as a primary reference for a design patent obviousness analysis.
The opinion can be found here.
Written by: Scott D. Eads and Nika Aldrich, Schwabe Williamson & Wyatt
Contributors: Erin Forbes and Bazsi Takacs
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…